Maximilian Koblischke

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Torque teno viruses exhaust and imprint the human immune system via the HLA-E/NKG2A axis.

Torque teno viruses exhaust and imprint the human immune system via the HLA-E/NKG2A axis.

Journal: Frontiers in immunology

Published: June 12, 2024

Autoreactive T cells targeting type II pneumocyte antigens in COVID-19 convalescent patients.

Autoreactive T cells targeting type II pneumocyte antigens in COVID-19 convalescent patients.

Journal: Journal of autoimmunity

Published: March 09, 2023

Immune Response after mRNA COVID-19 Vaccination in Lung Transplant Recipients: A 6-Month Follow-Up.

Immune Response after mRNA COVID-19 Vaccination in Lung Transplant Recipients: A 6-Month Follow-Up.

Journal: Vaccines

Published: June 08, 2022

Immune response after mRNA COVID-19 vaccination in heart transplant recipients: long-term follow-up and evaluation of a third vaccination.

Immune response after mRNA COVID-19 vaccination in heart transplant recipients: long-term follow-up and evaluation of a third vaccination.

Journal: European journal of preventive cardiology

Published: April 15, 2022

Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension study.

Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension study.

Journal: Annals of the rheumatic diseases

Published: March 31, 2022

Immunogenicity of COVID-19 Vaccinations in Hematological Patients: 6-Month Follow-Up and Evaluation of a 3rd Vaccination.

Immunogenicity of COVID-19 Vaccinations in Hematological Patients: 6-Month Follow-Up and Evaluation of a 3rd Vaccination.

Journal: Cancers

Published: March 15, 2022

Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial.

Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial.

Journal: Nature communications

Published: February 05, 2022

Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients: A Randomized Clinical Trial.

Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients: A Randomized Clinical Trial.

Journal: JAMA internal medicine

Published: December 20, 2021

Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomised controlled trial.

Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomised controlled trial.

Journal: Annals of the rheumatic diseases

Published: September 22, 2021

B Cell Depletion and SARS-CoV-2 Vaccine Responses in Neuroimmunologic Patients.

B Cell Depletion and SARS-CoV-2 Vaccine Responses in Neuroimmunologic Patients.

Journal: Annals of neurology

Published: September 17, 2021

SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity.

SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity.

Journal: Annals of the rheumatic diseases

Published: May 13, 2021

SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8+ T cell responses.

SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8+ T cell responses.

Journal: Science immunology

Published: January 19, 2021

Showing 1-12 of 18

Last Updated: 09/26/2026